Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04274426
Title Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRalpha) High Recurrent Ovarian Cancer (MIROVA)
Acronym MIROVA
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors AGO Research GmbH
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Charite Campus Virchow Klinikum RECRUITING Berlin Germany Details
Städtische Klinikum Dessau RECRUITING Dessau Germany Details
Universitätsklinikum Carl-Gustav-Carus an der Technischen Universität Dresden RECRUITING Dresden Germany Details
Universitätsklinikum Düsseldorf NOT_YET_RECRUITING Düsseldorf Germany Details
Evangelische Kliniken-Essen-Mitte RECRUITING Essen Germany Details
Universitätsklinikum Frankfurt RECRUITING Frankfurt Germany Details
Universitätsklinikum Hamburg Eppendorf RECRUITING Hamburg Germany Details
Medizinische Hochschule Hannover RECRUITING Hannover Germany Details
ViDia Christliche Kliniken Karlsruhe RECRUITING Karlsruhe Germany Details
HELIOS Klinikum Krefeld RECRUITING Krefeld Germany Details
St. Elisabeth-Krankenhaus GmbH RECRUITING Köln-Hohenlind Germany Details
Klinikum Mannheim RECRUITING Mannheim Germany Details
OnkoNet Marburg NOT_YET_RECRUITING Marburg Germany Details
Klinikum der Universität München RECRUITING München Germany Details
Rotkreuzklinikum München RECRUITING München Germany Details
TU München, Klinikum recht der Isar RECRUITING München Germany Details
Universitätsklinik Münster RECRUITING Münster Germany Details
Klinikum Südstadt Rostock RECRUITING Rostock Germany Details
Universitätsfrauenklinik Ulm RECRUITING Ulm Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field